• Non ci sono risultati.

Measuring the benefits and outcomes of CM. Clinical Pathways

N/A
N/A
Protected

Academic year: 2021

Condividi "Measuring the benefits and outcomes of CM. Clinical Pathways"

Copied!
23
0
0

Testo completo

(1)

Measuring the benefits

Measuring the benefits

and outcomes of CM:

and outcomes of CM:

Clinical Pathways

Clinical Pathways

Trish White BN MN (

Trish White BN MN (dist)dist)

Nurse Practitioner: Adult Urology

Nurse Practitioner: Adult Urology

Hawke’s Bay DHB

(2)

Outcomes

Outcomes

 Defined as the end result of a process, treatment or Defined as the end result of a process, treatment or intervention

intervention

 Traditionally mortality and morbidity – measures of Traditionally mortality and morbidity – measures of clinical outcomes and physiology

clinical outcomes and physiology

 Modern Parameters:Modern Parameters:

 Physiological Physiological

 Psychosocial (attitude, mood)Psychosocial (attitude, mood)  Behavioural (motivation)Behavioural (motivation)

 Functional (ADL’s)Functional (ADL’s)

 QOL (symptom control, well being)QOL (symptom control, well being)  Knowledge (medications, diet)Knowledge (medications, diet)

 Financial (costs of care)Financial (costs of care)

(3)

Why do it?

Why do it?

 Improves standard of careImproves standard of care

 How good is the care we are providing?How good is the care we are providing?  Measures the benefit of careMeasures the benefit of care

 BenchmarkingBenchmarking

 Promotes continuous quality improvementsPromotes continuous quality improvements

 Nurses should be critical thinkersNurses should be critical thinkers

 Clearly illustrates benefits of the roleClearly illustrates benefits of the role

 Justify roleJustify role

 Prove impact in a measurable wayProve impact in a measurable way

(4)

How I measure outcomes….

How I measure outcomes….

 Monthly reportMonthly report

 Linked to Nursing Council competencies Linked to Nursing Council competencies

 Clinical data: number of pts seen in ward, OPD, homeClinical data: number of pts seen in ward, OPD, home  Referral sources: Nurse, Urologist, GP, HospiceReferral sources: Nurse, Urologist, GP, Hospice

 Prevented admissionsPrevented admissions  Teaching sessionsTeaching sessions

 Professional activities: presentations, publication, mentoringProfessional activities: presentations, publication, mentoring

 Audits: readmissions, active review, day cases, blood Audits: readmissions, active review, day cases, blood transfusions, returns to OT

transfusions, returns to OT

 Clinical Pathways: variance monitoring reports Clinical Pathways: variance monitoring reports  ResearchResearch

(5)

Clinical Pathways

Clinical Pathways

Documentation of variance – key to

Documentation of variance – key to

improving patient outcomes”

improving patient outcomes”

Sheehan, Nursing Management, Feb 2002

(6)

Clinical Pathways: process

Clinical Pathways: process

 IT obtain patient data & enter onto Excel IT obtain patient data & enter onto Excel

spreadsheet spreadsheet

 Clinical audit of medical recordsClinical audit of medical records

 Manual input of clinical data into spreadsheetManual input of clinical data into spreadsheet  Report generatedReport generated

 Analysis by meAnalysis by me

 Feedback to clinicians (nursing and medical) Feedback to clinicians (nursing and medical)

& discussion & discussion

(7)

Hyperemesis Gravidarum

Hyperemesis Gravidarum

Multidisciplinary CP implemented in

Multidisciplinary CP implemented in

1999: input from nursing, dietitian &

1999: input from nursing, dietitian &

medical staff

medical staff

 HBDHB Quality Award, NZ Gynaecology HBDHB Quality Award, NZ Gynaecology

Nurses Conference best paper 2002 Nurses Conference best paper 2002

 Replaces daily flow chart Replaces daily flow chart  Ability to individualise Ability to individualise

(8)

HG – Length of Stay

HG – Length of Stay

CP CP Introduced Introduced LOS LOS days days Year Year

(9)

HG – Cost implications

HG – Cost implications

Pre Clinical Pathway

Pre Clinical Pathway

$85,367 per annum $85,367 per annum

Post Clinical Pathway

Post Clinical Pathway

$35 – 47,000 per annum $35 – 47,000 per annum

(10)

Readmissions

Readmissions

25% of patients readmitted

25% of patients readmitted

Aggressive management for readmissions

Aggressive management for readmissions

 NG feeding NG feeding

(11)

Ethnicity: July 03 – Dec 04

Ethnicity: July 03 – Dec 04

%

(12)

HG – Clinical Indicators

HG – Clinical Indicators

Demographics

Demographics

Nausea & Vomiting Day 2

Nausea & Vomiting Day 2

Ketones Day 2

Ketones Day 2

Ptyalism

Ptyalism

NG feeding

NG feeding

CP completion rates: ED & ward

CP completion rates: ED & ward

Potential to be used in PHC

Potential to be used in PHC

(13)

TURP Data

TURP Data

Implemented as guideline in 1998

Implemented as guideline in 1998

Variance Monitoring 2001

Variance Monitoring 2001

2002

2002

TURP volumes = 18.2% of surgery

TURP volumes = 18.2% of surgery

105 case weights = 28% of total

105 case weights = 28% of total

contract

(14)

TURP - LOS

TURP - LOS

(15)

Clinical Indicators

Clinical Indicators

Acute vs Elective

Acute vs Elective

Admission DOS

Admission DOS

CBI/MBI

CBI/MBI

Readmissions

Readmissions

Operating time

Operating time

Fever

Fever

Postop Hb

Postop Hb

TOV

TOV

LOS

LOS

(16)

Benchmarking

Benchmarking

 Benchmarking – (ACHS) Australian Council Benchmarking – (ACHS) Australian Council Healthcare Standards

Healthcare Standards

 Each variance has betweenEach variance has between

60 – 84 Health Care 60 – 84 Health Care

organisations reporting organisations reporting

figuresfigures

 Tissue weight, histology, blood Tissue weight, histology, blood

transfusions, operating time,transfusions, operating time,

readmissionsreadmissions

(17)

Outcomes – Last report:

Outcomes – Last report:

Reduced TURP LOS by 0.5 day

Reduced TURP LOS by 0.5 day

Plan to reduce readmissions in place

Plan to reduce readmissions in place

Frequency of postop blood tests

Frequency of postop blood tests

reviewed

reviewed

Difference in practice: CBI reviewed

Difference in practice: CBI reviewed

Rate of DOS admissions discussed

Rate of DOS admissions discussed

(18)

Hysterectomy

Hysterectomy

Includes: vaginal, abdominal &

Includes: vaginal, abdominal &

laparoscopic

laparoscopic

LOS further broken down by type of

LOS further broken down by type of

surgery & gynaecologist

surgery & gynaecologist

(19)

Hysterectomy - LOS

Hysterectomy - LOS

LOS LOS days days

(20)

Clinical Indicators

Clinical Indicators

 DemographicsDemographics

 Readmission rateReadmission rate  Admit DOSAdmit DOS

 Postop blood workPostop blood work  Intraoperative injuryIntraoperative injury

 IDCIDC

 Nausea & vomitingNausea & vomiting  FeverFever

 Bowel functionBowel function

(21)

Outcomes – last report:

Outcomes – last report:

 2004-2005 for first time Laparoscopic 2004-2005 for first time Laparoscopic

Hysterectomy has shortest length of stay Hysterectomy has shortest length of stay

 IDC removal and patients tolerating diet on IDC removal and patients tolerating diet on

Day 1 improved Day 1 improved

 Fever rate >38 increased – no trend notedFever rate >38 increased – no trend noted  HBDHB within ACHS benchmarksHBDHB within ACHS benchmarks

 Length of stay reducingLength of stay reducing  Readmission rate reducedReadmission rate reduced

(22)

Conclusions

Conclusions

 Clinical indicators selected on potential impact Clinical indicators selected on potential impact

to quality of care and LOS to quality of care and LOS

 Little benefit having clinical pathways without Little benefit having clinical pathways without

a robust VM system a robust VM system

 Clinical pathway an option even with different Clinical pathway an option even with different

techniques between clinicians techniques between clinicians

 Linking clinical outcomes with dataLinking clinical outcomes with data  Provides a guideline for staffProvides a guideline for staff

 Current method labour intensive Current method labour intensive

(23)

CLINICAL

CLINICAL

PATHWAYS

PATHWAYS

SHOULD NOT REPLACE

SHOULD NOT REPLACE

CLINICAL JUDGEMENT

Riferimenti

Documenti correlati

JLK

The importance of the secreted form of ANXA1 in cellular motility was confirmed when MIA PaCa-2 were compared with PANC-1 cells that lack both the cleaved and the

Programmers must utilise vectorisation (SIMD) and OpenMP threads, and possibly the fast memory of KNL. For the user, MD performances will depend on how software developers are

In De l’esprit des lois Montesquieu shows that a multitude of variables in a society, including the laws, commerce, and religion, interact with one another to

capsici AZ78 genome was mined for genes potentially involved in the production of antibiotics and a genomic region of 9489 bp missing in Sm K729a and Xcc ATCC 33913 was

Based on the results of the single-topic classification of LOD datasets, for the development of the multi-topic benchmark we consider some criteria for the selection of the

Anyway, the highest earliness registered during the bioassay corresponded to the lowest value of ABA content, which corresponded also to the lowest value of mean days

Anche dal confronto grafico della statura, tra il campione sardo e gli standard del sud Italia, si può notare come sia per i maschi sia per le femmine, i valori del 3°, 50° e